Bioprocessing
Accelerate biotherapeutics discovery and development timelines with Waters Process Analytical Technology (PAT) solutions for upstream and downstream process development.
Biologics are groundbreaking therapeutics that offer patients options for newer, more efficient, and safer treatment. Bioprocessing is a critical part of biologics development to ensure efficient therapeutic product manufacturing and to meet regulatory requirements with critical quality attributes (CQAs) in check.
To accelerate time to market for biologics, bioprocess development and manufacturing require advanced process analytical technologies (PAT) for high-throughput, in-depth monitoring of critical process parameters (CPPs) and CQAs – to obtain high-quality data with speed, robustness, and throughput.
Obtain bioprocess analytics with Waters solutions and end-to-end workflows, and bring advanced PAT tools such as LC-MS into your discovery, process development, and manufacturing to fully support analytical needs.
With Waters, you can:
- Achieve success through discovery and development with deeper process understanding
- Accelerate process development with streamlined workflows while minimizing human intervention and avoid human errors
- Reduce operational costs by quickly and efficiently accessing data at point of need
